The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Growing patent filings and tier-2 innovators reflect expanding national research base
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
CD388 is administered as a single 450-milligram subcutaneous dose in adults and adolescents
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Subscribe To Our Newsletter & Stay Updated
